Allergy

1. CHARPY J, Seydoux M, Giraudon A, Bonnac J, et al
   Correspondence to 'Hypersensitivity Reactions to Human Albumin-A Case Series and Diagnostic Algorithm'.
   Allergy. 2025 Nov 27. doi: 10.1111/all.70168.
   

   >> Share

   
   
2. DU CW, Wang JH, Pereda J, Jakasa I, et al
   Assessment of the Severity of Atopic Dermatitis Using Atomic Force Microscopy Analysis of Skin Tape Strips.
   Allergy. 2025 Nov 26. doi: 10.1111/all.70170.
   

   >> Share

   
   
3. TODOROVIC N, Trifonova D, Liu Z, Curin M, et al
   Major Cat Allergen Fel d 4: Structure and Identification of a Cross-Reactive IgE-Epitope-Containing Area.
   Allergy. 2025 Nov 24. doi: 10.1111/all.70146.
   

   >> Share

   
   
4. POUESSEL G, Divaret-Chauveau A, Herrero SI, Garriga-Baraut T, et al
   Reply to Correspondence "Anaphylaxis Induced by Goat's and Sheep's Milk-A Rare Entity in Europe".
   Allergy. 2025 Nov 24. doi: 10.1111/all.70158.
   

   >> Share

   
   

   
   Ann Allergy Asthma Immunol

5. ONGTENGCO A, Wilt E, Hardy P, Youssef C, et al
   "Getting in and doing it personally": Engagement Strategies for Rural School Asthma Programs.
   Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00377.
   

   >> Share

   
   
6. FINEMAN S, Hernandez-Trujillo V, Joshi SR, Knox SM, et al
   From the pages of AllergyWatch.
   Ann Allergy Asthma Immunol. 2025;135:714-715.
   

   >> Share

   
   
7. WONG LSY, Schmidt B, Jarvinen KM, Groetch M, et al
   From breast to bite: Nutritional management in infantile food protein-induced enterocolitis syndrome (FPIES).
   Ann Allergy Asthma Immunol. 2025;135:626-633.
   

   >> Share

   
   
8. ANVARI S, Gupta M, Nicolaides R, Morita H, et al
   The evolution of food protein-induced enterocolitis syndrome (FPIES): Global trends, emerging triggers, and natural history.
   Ann Allergy Asthma Immunol. 2025;135:616-625.
   

   >> Share

   
   
9. TIOTIU A, Pilette C, Bagnasco D, Bondi B, et al
   Comparative analysis of biologics' effects on lung function parameters in severe asthma.
   Ann Allergy Asthma Immunol. 2025 Sep 6:S1081-1206(25)01156.
   

   >> Share

   
   
10. PATERSON F, On JY, Ahmed D, Poto R, et al
    Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
    Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
    

    >> Share

    
    
11. BIAGI M, Pucci C, Puxeddu I, Migliorini P, et al
    Ultrarush protocol safety and efficacy in Hymenoptera venom immunotherapy.
    Ann Allergy Asthma Immunol. 2025;135:676-680.
    

    >> Share

    
    
12. BERNATONIENE J, Bourgoin-Heck M, Cancian M, Yang W, et al
    Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim results.
    Ann Allergy Asthma Immunol. 2025;135:681-688.
    

    >> Share

    
    

    
    Arch Pediatr

13. CHERIF H, Berkaoui G, Yangui F, Mokaddem S, et al
    Retrospective descriptive and analytical study of trends in the clinical and allergenic profiles of atopic children in a Mediterranean Country (1992-2022).
    Arch Pediatr. 2025 Nov 24:S0929-693X(25)00215.
    

    >> Share

    
    

    
    BMC Pediatr

14. ZHANG P, Ai T, Wang L, Luo R, et al
    Exploring the indicative role of ACT score in improving lung function in asthmatic children undergoing dust mite immunotherapy.
    BMC Pediatr. 2025;25:951.
    

    >> Share

    
    
15. GUNGOR E, Orhan O, Dogan S, Buyuksahin HN, et al
    Evaluation of the relationship between lung ultrasound findings and degree of obstruction in newly diagnosed pediatric asthma patients.
    BMC Pediatr. 2025;25:959.
    

    >> Share

    
    

    
    BMJ

16. MAHASE E
    GPs must add extra checks after patient dies from penicillin allergy mix-up.
    BMJ. 2025;391:r2513.
    

    >> Share

    
    

    
    Br J Dermatol

17. MILTNER LA, Loman L, Ortiz JA, Zhang J, et al
    Multimorbidity and Atopic Dermatitis in a Population-Based Cohort: Severity-Dependent Association With Distinct Non-Atopic Multimorbidity Patterns.
    Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093.
    

    >> Share

    
    
18. ZHAO M, Xu Z, Wu L, Wei Z, et al
    Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial.
    Br J Dermatol. 2025 Nov 24:ljaf455. doi: 10.1093.
    

    >> Share

    
    

    
    Eur J Dermatol

19. TOYOSHIMA M, Nakaoji K, Hamada K, Yamanaka A, et al
    Analysis of skin aging patterns using a facial imaging system in atopic dermatitis patients of 20-34 years old.
    Eur J Dermatol. 2025;35:424-426.
    

    >> Share

    
    

    
    J Dermatol

20. KOIKE Y, Morisaki H, Motooka D, Matsumoto M, et al
    Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
    

    >> Share

    
    

    
    Lancet

21. GUTTMAN-YASSKY E, Kabashima K, Worm M, Luna PC, et al
    Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.
    Lancet. 2025 Nov 25:S0140-6736(25)01865-3. doi: 10.1016/S0140-6736(25)01865.
    

    >> Share

    
    
22. ATASH K, Boesjes CM, de Bruin-Weller MS
    Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.
    Lancet. 2025 Nov 25:S0140-6736(25)02152-X. doi: 10.1016/S0140-6736(25)02152.
    

    >> Share

    
    
23. BIESIEKIERSKI JR, Jonkers D, Ciacci C, Aziz I, et al
    Non-coeliac gluten sensitivity.
    Lancet. 2025;406:2494-2508.
    

    >> Share

    
    

    
    Pediatr Dermatol

24. 
    inverted question markQue es la dermatitis atopica?
    Pediatr Dermatol. 2025;42:E1-E2.
    

    >> Share

    
    
25. 
    What is atopic dermatitis?
    Pediatr Dermatol. 2025;42:1270-1271.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share